NEW ORLEANS – Results of two company-funded studies clinical studies presented at the American College of Cardiology (ACC; Washington) meeting in the Big Easy this week demonstrate that the Resolute drug-eluting stent (DES) from Medtronic (Minneapolis) provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease. (Medical Device Daily) Read More
